HyGel™
Printer-friendly version
HyGel™ is a high concentration (2.5%) hyaluronic acid (HA)-based gel. Ionic Polymer Matrix (IPM) technology provides sustained delivery of HA.
HyGel™ is indicated for management of exudating wounds such as leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds (post-operative and donor sites), mechanically or surgically debrided wounds, and for second-degree burns.
HyGel™ is indicated for the management and relief of burning, itching, and pain associated with various types of dermatoses; including atopic dermatitis, allergic contact dermatitis and radio-dermatitis.
| Antimicrobial format available | |
| Clear | |
| Compatible w/ topicals | |
| Conforms readily to wound | ● |
| Limited shelf life | |
| Moisture vapor permeable | |
| Powder form | |
| Preserved multiple dose | |
| Secondary dressing required | ● |
| Unpreserved unit dose | |
| Usable on infected wounds |
Acute Wounds
Burns
Diabetic Foot
Dry Skin Conditions
Moderate/Highly Exudating Wounds
Pressure Ulcers
Surgical Wounds
Gentex Pharma is a privately held, specialty pharmaceutical company focusing on the development, marketing, and distribution of niche pharmaceuticals.